FIELD: inorganic syntheses. SUBSTANCE: amorphous aluminosilicate derivatives are prepared by reaction of corresponding solid initial material with MOH, wherein M is alkali metal cation or hydroxide. The former can be selected from group including montmorillonite, kaolin, naturally occurring zeolite (e.g. clinoptilonite/heulandite), and also illite, palygorskite, and saponite. MOH can be supplemented by reagent MX, in which X is halogen. Invention also covers aluminosilicate derivatives having general formulas. EFFECT: enabled preparation of derivatives with prevailing tetrahedrally coordinated aluminum increasing number of exchangeable ligands. 13 cl, 16 dwg, 11 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| ALUMOSILICATES DERIVATIVES | 1995 |
|
RU2146651C1 |
| METHOD OF COATING NONCONDUCTING SUBSTRATE (VERSIONS) | 1995 |
|
RU2152911C2 |
| AMORPHOUS KAOLIN DERIVATIVE AND METHOD OF PREPARATION THEREOF | 1994 |
|
RU2136593C1 |
| PURIFIED DERIVATIVES OF SULFOALKYL ETHERS OF CYCLODEXTRINE OR THEIR MIXTURE, CLATRATE COMPLEX OF CYCLODEXTRINE DERIVATIVES WITH MEDICINAL, AND PHARMACEUTICAL COMPOSITION | 1993 |
|
RU2113442C1 |
| METHOD FOR CARBONYLATION OF ALIPHATIC ALCOHOLS AND/OR REACTIVE DERIVATIVES THEREOF | 2006 |
|
RU2458909C2 |
| USE OF POROUS MATERIALS FOR INHIBITING/DISTURBING THE SENSE OF QUORUM OF BACTERIA | 2017 |
|
RU2724550C2 |
| SYNTHETIC SWELLING CLAY MINERALS | 1995 |
|
RU2163224C2 |
| METHOD OF PURIFYING NON-MODIFIED MONTMORILLONITE-BASED BENTONITE | 2013 |
|
RU2520434C1 |
| PURIFIED DERIVATIVE OF CYCLODEXTRINE, CLATHRATE COMPLEX OF PURIFIED DERIVATIVE OF CYCLODEXTRINE WITH DRUG, PHARMACEUTICAL COMPOSITION | 1992 |
|
RU2099354C1 |
| SURFACE STRUCTURE MODIFYING | 2009 |
|
RU2539343C2 |
